- In March 2025, a leading diagnostic company in North America launched a new rapid molecular diagnostic assay that can identify common bloodstream pathogens and antibiotic resistance genes directly from blood samples within a few hours, significantly reducing the turnaround time compared to traditional blood culture methods.
- In January 2025, a major hospital network in the U.S. implemented a fully automated blood culture system across its facilities to improve efficiency, reduce contamination rates, and enhance the speed of diagnosis for bloodstream infections.
